aTYR Director Buys Stock
aTYR Pharma director Paul Schimmel purchases common stock, showing insider confidence. The buy is worth forty nine thousand six hundred thirty dollars.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.